GLPG5101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GLPG5101, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma [Phase 1, Phase 2]